Physician profile
Thomas Rajan
NPI 1184739849
$611.26
in general payments reported to CMS, 2019-2025
11 companies · $54.22 in 2025
The $54.22 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59.37 · 2020: $111 · 2021: $95.00 · 2022: $168 · 2023: $93.88 · 2024: $29.69 · 2025: $54.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $137 · Education: $40.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $137.35 |
| Education | $40.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $112.77 | 2019-2023 | Lokelma |
| Vifor Pharma, INC. | $109.48 | 2020-2022 | |
| Amgen INC. | $99.69 | 2022-2024 | Krystexxa |
| Otsuka America Pharmaceutical, INC. | $52.52 | 2019-2023 | Jynarque |
| Horizon Therapeutics Plc | $49.74 | 2023 | Krystexxa |
| Opko Pharmaceuticals, LLC | $48.20 | 2019-2020 | |
| Glaxosmithkline, LLC. | $46.86 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $40.44 | 2025 | |
| Insmed, INC. | $22.58 | 2022 | |
| Alexion Pharmaceuticals, INC. | $15.20 | 2021 | |
| Ani Pharmaceuticals, INC. | $13.78 | 2025 | Purified Cortrophin Gel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Rajan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.